Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. - Wikidata - wikimedia - TriplyDB

Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

http://www.wikidata.org/entity/Q33913718

about

Selective gene silencing by viral delivery of short hairpin RNA miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes Bone site-specific delivery of siRNA Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling Delivery of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles.Cell cycle-dependent Rho GTPase activity dynamically regulates cancer cell motility and invasion in vivo Technologies for controlled, local delivery of siRNA Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells Therapeutic potential of RNA interference against cancer Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target Photomechanical wave-driven delivery of siRNAs targeting intermediate filament proteins promotes functional recovery after spinal cord injury in rats Nano delivers big: designing molecular missiles for cancer therapeutics.Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect.RNAi reduces expression and intracellular retention of mutant cartilage oligomeric matrix protein.Lipid-like materials for low-dose, in vivo gene silencing Advances in Systemic siRNA Delivery Optical imaging-guided cancer therapy with fluorescent nanoparticles Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway.The Effect of Sodium Valproate on the Glioblastoma U87 Cell Line Tumor Development on the Chicken Embryo Chorioallantoic Membrane and on EZH2 and p53 Expression.Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.EZH2 depletion blocks the proliferation of colon cancer cells.Image-guided breast tumor therapy using a small interfering RNA nanodrug Assessing siRNA pharmacodynamics in a luciferase-expressing mouse.Photofrin based photodynamic therapy and miR-99a transfection inhibited FGFR3 and PI3K/Akt signaling mechanisms to control growth of human glioblastoma In vitro and in vivo.A robust in vivo positive-readout system for monitoring siRNA delivery to xenograft tumors.Local applications of myostatin-siRNA with atelocollagen increase skeletal muscle mass and recovery of muscle function MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery Innovative delivery of siRNA to solid tumors by super carbonate apatite.Efficient inhibition of tumor angiogenesis and growth by a synthetic peptide blocking S100A4-methionine aminopeptidase 2 interaction.Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling Atelocollagen-mediated systemic delivery prevents immunostimulatory adverse effects of siRNA in mammals.RNA therapeutics targeting osteoclast-mediated excessive bone resorption.Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis MicroRNA Involvement in Osteosarcoma.Targeted Knockdown of the Kinetochore Protein D40/Knl-1 Inhibits Human Cancer in a p53 Status-Independent Manner.RNA interference targeting carbohydrate sulfotransferase 3 diminishes macrophage accumulation, inhibits MMP-9 expression and promotes lung recovery in murine pulmonary emphysema Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials.

P2860

Q21245112-1D0CA615-6F30-4B43-9BC7-D99BBE9C97CD Q24604354-23697643-0DEC-4A12-A7E2-D1476BF00CA8 Q24628676-4E503580-5314-4843-AFAC-35BD8CB19C08 Q26773973-8D249322-BDE7-49C3-95E9-092CE7EC09A3 Q27314385-64E0C2AC-C6C8-4074-9C9A-B5FFE1AFD6CD Q27335339-90F54CD3-624E-4E20-9100-76D4E881C5F2 Q27339470-D98323A8-8CBB-4869-A99B-050115B58350 Q28087657-E1ED345F-DB39-4117-81A3-4EC9BCC80C0C Q28249223-CA0CFA8F-1C2E-486C-B325-2C7103126BF5 Q28253746-8E091CCB-9528-4669-A03C-001313558301 Q28266775-EACEEE6A-00BE-4D4D-A4C7-EDE4837C9F67 Q30459711-0C40DDBC-41B2-4942-9626-A1D262D7C636 Q30470080-DB12380F-B195-4581-8F7E-A24379E310E7 Q33265007-3F7FD0CF-34B0-46D8-A6B5-E8D2571ACB59 Q33565464-F95EAE3A-42FF-46E6-976A-E5E11383A342 Q33583399-92E97123-A1E9-4BF8-8774-61CF51E3F340 Q33613316-65F0CE3F-ABE0-4A8B-97E7-C905B488816A Q33731037-DE50BAB9-2040-46EC-A1E8-5B65FC306E24 Q33764131-7007F88C-A4AC-4DD8-81DB-C35CE7E4F1EE Q33794860-6108A0F1-8564-4C13-AD9A-819A2C07E990 Q33935474-BB0E30D5-4713-4177-B64A-9F6EEE3254FF Q33963796-22F169D9-CF28-45F1-B472-20CCFD567719 Q34168738-B0E6DA58-E59D-422E-B7D6-2248C04901C4 Q34457509-4B9124EC-780F-480A-8687-9BB734A83ECA Q34586177-529E75EC-6DEB-4232-B98C-48059D022D5D Q34706669-01AC0B23-34BA-4259-9536-AC80896F1C2E Q34746296-3B7424A6-5BC5-45A9-85BF-18001605B424 Q35086698-13E44546-9A08-471A-A9A3-C3BD0C7466D9 Q35172957-ACDED00D-7057-40BC-B1FA-7F10AE0F93E7 Q35238275-84ECBEB6-C478-43C1-A05E-4EC9427B894A Q35571504-3AA9E8C8-54A9-4083-88E1-6A8A87C65436 Q35651091-9C6BCE3F-4AAA-4DD1-A59F-33BCED3A73B8 Q35657424-F625E7AA-B812-4980-9013-EE87FBC71E94 Q35750040-C783CE29-BEE8-4EB8-9ED4-59706A6AE238 Q35800463-49825882-C33C-4342-884B-9F1AA99C4660 Q35837122-2769B5FE-2CF6-475C-A92A-00ECDCA0780A Q35898407-6A9D378E-225C-407B-9D89-3AA143AEC49F Q36035358-0E065199-5380-4306-8067-37DC21D14230 Q36358172-1DB99C7B-840C-42A9-98C3-E3442F9366F6 Q36401746-01738F50-95EC-451B-A9F8-F513D4F3B572

P2860

Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

http://www.wikidata.org/entity/Q33913718

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Efficient delivery of small in ...... y using atelocollagen in vivo.

@ast

Efficient delivery of small in ...... y using atelocollagen in vivo.

@en

type

label

Efficient delivery of small in ...... y using atelocollagen in vivo.

@ast

Efficient delivery of small in ...... y using atelocollagen in vivo.

@en

prefLabel

Efficient delivery of small in ...... y using atelocollagen in vivo.

@ast

Efficient delivery of small in ...... y using atelocollagen in vivo.

@en

P1433

Q33913718-ECA39C76-7EAA-4E5D-900F-4BB387AA1FF5

P1476

Q33913718-5E3CA9D8-37F1-45B8-8BC9-5D27C6AB5267

P2093

Q33913718-12EF30F4-57F7-4FD6-B40E-5F5A3F5C4673

Q33913718-2B148642-F705-4A8C-A958-8ABAD26B6995

Q33913718-3E09BBCE-EA7B-4CC0-966D-FE36D4216F84

Q33913718-55FE6FF1-1325-494C-898B-93FE927368EF

Q33913718-6CAF9D26-EA6C-4E24-B632-407787D6C0FE

Q33913718-85EE0E4B-0A27-40A9-88DB-ECEF82E25AA3

Q33913718-894CBA49-6158-4FC1-9B44-A05C94C26AFF

Q33913718-9E4ECED2-09C8-4DCB-B6B1-828F2D78B952

Q33913718-A4D6576C-36FD-4EE7-AA3F-6CA3A540C521

Q33913718-B1D49DF5-198B-4530-863A-C47815ACFEC2

P2860

Q33913718-1569CDAC-3E6D-4F21-B2BD-02CA3CAD2FBF

Q33913718-1F8209EF-96ED-4627-9F29-408773319D7E

Q33913718-220D68F7-2A65-4329-8AC3-22337A129DEC

Q33913718-38C506F6-52C0-4CBC-9D40-7FF46008CBF9

Q33913718-410C9174-F874-4D5E-BA12-20BC184A9175

Q33913718-43CA3F7E-5533-4F5D-8B19-D20FB07016EA

Q33913718-473F8163-EBB3-4D8E-9F38-B0DDF2251C13

Q33913718-62DEE33E-237A-4B65-A34B-AE58FB53E8B7

Q33913718-6C559506-CF9F-4D47-A67B-1110B3D47406

Q33913718-6DAD0867-38DE-4615-85FB-7A1F56EA88C5

P304

Q33913718-147A508C-CC2F-4660-AA8D-F6818A6BCF60

P31

Q33913718-8CF0656F-2B23-4EEA-9D02-61DEFE8BFAF2

P356

Q33913718-DA6BB4FE-FC82-4136-8DB3-0020BE5378AC

P407

Q33913718-C2C3A8DC-387F-4A33-8534-BD5C78045A33

P433

Q33913718-C885ACF0-3912-4CCB-BBFE-E82F8EC5DF5E

P478

Q33913718-1519E8CD-75FD-4122-A61D-8733769DED90

P50

Q33913718-4D742B04-B3B1-4BD1-89B9-AB90EC9EC375

P577

Q33913718-4D87487E-E7DD-4953-90F2-0500258C1BC6

P5875

Q33913718-36FABD62-A384-4CC3-8D1B-37F71665A372

P698

Q33913718-4AFE41D1-3255-4DB0-97BE-923CB7052DCE

P932

Q33913718-A1BA9CC6-3758-408A-B5B2-0764E2C99494

P356

PNAS.0501753102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Efficient delivery of small in ...... by using atelocollagen in vivo

@en

P2093

Akihiko Sano

http://www.w3.org/2001/XMLSchema#string

Fumitaka Takeshita

http://www.w3.org/2001/XMLSchema#string

Hideo Sasaki

http://www.w3.org/2001/XMLSchema#string

Kimi Honma

http://www.w3.org/2001/XMLSchema#string

Koji Hanai

http://www.w3.org/2001/XMLSchema#string

Kotaro Hirai

http://www.w3.org/2001/XMLSchema#string

Nachi Namatame

http://www.w3.org/2001/XMLSchema#string

Shunji Nagahara

http://www.w3.org/2001/XMLSchema#string

Takahiro Ochiya

http://www.w3.org/2001/XMLSchema#string

Takumi Teratani

http://www.w3.org/2001/XMLSchema#string

P2860

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

The polycomb group protein EZH2 is involved in progression of prostate cancer

Expression profiling reveals off-target gene regulation by RNAi

Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.

siRNA-mediated gene silencing in vitro and in vivo.

Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.

Unlocking the potential of the human genome with RNA interference.

In vivo activity of nuclease-resistant siRNAs

Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines.

P304

12177-12182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0501753102

http://www.w3.org/2001/XMLSchema#string

P407

P433

34

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7669823

http://www.w3.org/2001/XMLSchema#string

P698

16091473

http://www.w3.org/2001/XMLSchema#string

P932

1183487

http://www.w3.org/2001/XMLSchema#string